A Mechanistic Map of the Phenotypic Complexity in Recessive Dystrophic Epidermolysis Bullosa Provides Basis for Therapeutic Target Discovery and Drug Repurposing
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27198436 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Sara Herráiz-Gil und 9 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Bioingeniería, Universidad Carlos III de Madrid, ROR Code 03ths8210, Avenida de la Universidad, 30 (Edificio Sabatini), 28911 Leganés…. Hauptthemen laut MEDLINE: Epidermolysis Bullosa Dystrophica, Drug Repositioning, Drug Discovery. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish Ministry of Science and Innovation, European Regional Development fund, Instituto de Salud Carlos III.
Abstract (Originalsprache)
Recessive dystrophic epidermolysis bullosa (RDEB) is a genodermatosis caused by loss-of-function mutations in the COL7A1 gene, producing a complex and heterogeneous phenotype. Clinical manifestations include skin fragility, local and systemic inflammation, impaired wound healing, dysbiosis, pain, and pruritus, increasing the risk of skin cancer. This work aimed to develop an actionable model of RDEB’s molecular mechanisms to identify and prioritize therapeutic targets for drug repurposing. Transcriptomic data of skin biopsies from pediatric RDEB patients and unaffected individuals were used to build the mechanistic map of the disease. This model, combined with machine learning, made it possible to infer actionable targets from the map circuits and identify candidate drugs capable of reversing the transcriptomic alterations. The resulting map is defined by 13 altered signaling circuits and 10 effector proteins which were linked to disease hallmarks including inflammation, fibrosis, and tumor progression. Analysis of the map identified 66 actionable targets with 74 drug candidates. Among them, overrepresentation analysis showed enrichment of phosphodiesterases and antineoplastic and immunomodulating agents. Finally, 16 drugs were prioritized for their potential to revert circuit alterations without potentiating unintended effects, with bendroflumethiazide and ibutilide showing the highest impact. This mechanistic model delivers the first functional disease map of RDEB and reveals promising therapeutic candidates targeted by approved drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Bioingeniería, Universidad Carlos III de Madrid, ROR Code 03ths8210, Avenida de la Universidad, 30 (Edificio Sabatini), 28911 Leganés, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER-ISCIII), 28029 Madrid, Spain.
- Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain.
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain.
- Platform for Computational Medicine, Andalusian Public Foundation Progress and Health-FPS, 41092 Seville, Spain.
- Computational Systems Medicine, Institute of Biomedicine of Seville (IBIS), Hospital Virgen del Rocío, 41013 Seville, Spain.
ORCID-Profile: Sara Herráiz-Gil, Miriam Payá-Milans, María Del Carmen de Arriba, Lucía Martínez-Santamaría, Carlos Loucera, Nuria Illera, Marcela Del Río, Joaquín Dopazo, Carlos León, María José Escámez
Förderung
- Spanish Ministry of Science and Innovation
- European Regional Development fund
- Instituto de Salud Carlos III
- Berritxuak
- DEBRA Spain
- CIBERER ISCIII
- DEBRA Austria, co-funded by DEBRA Sweden and EB-LOPPET
- UC3M-PhD research training scholarship
Zitieren
APA
Herráiz-Gil, S., Payá-Milans, M., de Arriba, M. D. C., Martínez-Santamaría, L., Loucera, C., Illera, N., Del Río, M., Dopazo, J., León, C., & Escámez, M. J. (2026). A Mechanistic Map of the Phenotypic Complexity in Recessive Dystrophic Epidermolysis Bullosa Provides Basis for Therapeutic Target Discovery and Drug Repurposing. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27198436
Vancouver
Herráiz-Gil S, Payá-Milans M, de Arriba MDC, Martínez-Santamaría L, Loucera C, Illera N, et al. A Mechanistic Map of the Phenotypic Complexity in Recessive Dystrophic Epidermolysis Bullosa Provides Basis for Therapeutic Target Discovery and Drug Repurposing. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27198436
BibTeX
@article{HerrizGil2026,
author = {Herráiz-Gil, Sara and Payá-Milans, Miriam and de Arriba, María Del Carmen and Martínez-Santamaría, Lucía and Loucera, Carlos and Illera, Nuria and Del Río, Marcela and Dopazo, Joaquín and León, Carlos and Escámez, María José},
title = {A Mechanistic Map of the Phenotypic Complexity in Recessive Dystrophic Epidermolysis Bullosa Provides Basis for Therapeutic Target Discovery and Drug Repurposing},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27198436}
}
EUVIMED